Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Updated:
May 29, 2024
Sourcebio International PLC
Cash Equivalents
|
Sourcebio International PLC
Cash Equivalents Peer Comparison
Comparables:
KOO
G
GENI
TLY
T
TRLS
MGP
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sourcebio International PLC
LSE:SBI
|
Cash Equivalents
£33.3m
|
CAGR 3-Years
218%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Cash Equivalents
£11m
|
CAGR 3-Years
12%
|
CAGR 5-Years
95%
|
CAGR 10-Years
N/A
|
|
G
|
Genincode PLC
LSE:GENI
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Totally PLC
LSE:TLY
|
Cash Equivalents
£1.7m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Cash Equivalents
$12.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medica Group PLC
LSE:MGP
|
Cash Equivalents
£11m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Sourcebio International PLC's Cash Equivalents?
Cash Equivalents
33.3m
GBP
33.3m
GBP
Based on the financial report for Dec 31, 2021, Sourcebio International PLC's Cash Equivalents amounts to 33.3m GBP.
What is Sourcebio International PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
218%
218%
Over the last year, the Cash Equivalents growth was 295%. The average annual Cash Equivalents growth rates for Sourcebio International PLC have been 218% over the past three years .
You don't have any saved screeners yet
